SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000812796-09-000067
Filing Date
2009-08-14
Accepted
2009-08-14 15:36:27
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 DOR 10-Q 2Q 2009 form10q.htm 10-Q 660501
2 DOR CEO 302 CERT 2Q 2009 ex31_1.htm EX-31.1 11017
3 DOR CFO 302 CERT 2Q 2009 ex31_2.htm EX-31.2 10707
4 DOR CEO 906 CERT 2Q 2009 ex32_1.htm EX-32.1 5186
5 DOR CFO 906 CERT 2Q 2009 ex32_2.htm EX-32.2 5220
  Complete submission text file 0000812796-09-000067.txt   694246
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 091015391
SIC: 2834 Pharmaceutical Preparations